Listen Aphasia Pilot Study (NCT07732140)

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

1. Patient inclusion criteria are as follows:
2. A histologically or cytologically confirmed primary or secondary brain tumor with expected ongoing deterioration in language as determined by their oncologist
3. Mild-to-moderate aphasia or other acquired communication disorder as determined by their oncologist or speech-language pathologist
4. ECOG Performance Status of ≤2 or Karnofsky Performance Status ≥60
5. Expected overall survival of \>6 months
6. Ability to understand and the willingness to sign a written consent form
7. Age ≥18 years
8. Willingness to participate in study interviews and be recorded for the study (for monitoring of study fidelity)
9. Cancer survivors will also be included Care-partner inclusion criteria are as follows:
10. Identified by their patient as someone who is integral to their care
11. Age ≥18 years
12. Ability to understand and the willingness to sign a written consent form

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (2 Sites)

• Brigham & Woman's Hospital — Boston, Massachusetts
• Dana-Farber Cancer Center — Boston, Massachusetts

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.